Brief: Enlivex Therapeutics Files Prospectus Supplement Related To Offering Of Ordinary Shares - SEC Filing
09/02/2021 23:47
Feb 9 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX THERAPEUTICS FILES PROSPECTUS SUPPLEMENT RELATED
TO
OFFERING OF ORDINARY SHARES - SEC FILING
Source text for Eikon: [ID: https://bit.ly/2N9D4Ra]
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment